Search Results for "Http Dx Doi Org 10 1002 Adma 201104290"

03:52 EDT 30th August 2015 | BioPortfolio

Matching Channels

Freiberg Infraction

Freiberg's disease is an osteochondrosis of the metatarsal head, most commonly occurring in young athletes older than 12 years who perform on their toes in either sprinting or jumping activities...

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html    

Pediculosis - louse (lice) infestation

   To view our most recent article on Lice Infestation please go to: http://www.bioportfolio.com/news/article/987568/Pediculosis-Louse-Lice-Infestation.html 

Pediculosis - louse (lice) diagnosis

   To view our most recent articals on Lice Diagnosis please view: http://www.bioportfolio.com/news/article/987588/Pediculosis-Louse-Lice-Diagnosis.html

G-protein-coupled receptors (GPCRs)

GPCRs are a large family of cell surface receptors that respond to a variety of external signals. Binding of a signaling molecule to a GPCR results in G protein activation, which in turn triggers th...

Matching News

Oxford provides up to $21mm in debt financing to ADMA Biologics

Oxford Finance provided infectious disease-focused ADMA Biologics Inc. with an initial $16mm loan to repay an existing loan. ADMA has the option to draw down another $5mm upon the approval of its BLA ...

Esperion hits record high on ETC-1002 results

Shares of Esperion Therapeutics Inc. (NASDAQ:ESPR) jumped $22.50 (29%) to $99.60, hitting an all-time high on Tuesday after the company said ETC-1002 met the primary endpoint of lowering LDL-cholester...

ADMA Biologics seeks FDA approval for primary immunodeficiency treatment

A biologics license application has been filed with the FDA by ADMA Biologics for approval to market its RI-002 as a treatmen -More- 

ADMA Biologics nets $9.2mm via FOPO

Infectious disease-focused ADMA Biologics Inc. netted $9.2mm through the follow-on offering of 1.2mm common shares at $8 each. Proceeds will help fund the anticipated launch of its lead antibody candi...

ADMA Biologics nets $10.6mm via FOPO

Infectious disease-focused ADMA Biologics Inc. netted $10.6mm through the follow-on offering of 1.4mm common shares (including the overallotment) at $8 each. Proceeds will help fund the anticipated la...

Esperion Therapeutics Announces Positive Top-Line Phase 2b Results for ETC-1002 Added to Stable Statin Therapy in Patients With Hypercholesterolemia

ANN ARBOR, MI--(Marketwired - March 17, 2015) - Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-densit...

ADMA completes debt financing

ADMA Biologics Inc completes follow-on

Matching PubMed Articles

First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.

Placental growth factor (PGF), soluble fms-like tyrosine kinase 1 (sFLT1) and asymmetric dimethylarginine (ADMA) are involved in the pathogenesis of preeclampsia. Abnormal maternal sFLT1, PGF and ADMA...

Physical exercise reduces synthesis of ADMA, SDMA, and L-Arg.

Increased levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and low plasma level of L-arginine (L-ARG) are all conditions likely to decrease nitric oxide (NO) production....

Endothelial DDAH1 is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.

-Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthesis and a risk factor for cardiovascular disease. Dimethylarginine dimethylaminohydrolase (DDAH) enzymes are respon...

Enhance Cancer Cell Recognition and Overcome Drug Resistance Using Hyaluronic Acid and α-Tocopheryl Succinate Based Multifunctional Nanoparticles.

Multidrug resistance (MDR) presents a clinical obstacle to cancer chemotherapy. The main purpose of this study was to evaluate the potential of a hyaluronic acid (HA) and α-tocopheryl succinate (α-T...

Probucol Protects Against Asymmetric Dimethylarginine-Induced Apoptosis in the Cultured Human Brain Microvascular Endothelial Cells.

Asymmetric dimethylarginine (ADMA) is emerging as a key contributor to endothelial dysfunction. The drug probucol was reported to have an anti-lipid peroxidation effect and improve endothelial dilatio...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement